Reply to: PCWG4: A Missed Opportunity to Make Bone-Protective Agents Mandatory for Patients With Bone Metastatic Castration-Resistant Prostate Cancer.
Journal articles
- Journal Article
Morris, MJ; Armstrong, AJ
Published in: J Clin Oncol
September 20, 2026
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
September 20, 2026
Volume
44
Issue
27
Start / End Page
2648 / 2649
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Morris, M. J., & Armstrong, A. J. (2026). Reply to: PCWG4: A Missed Opportunity to Make Bone-Protective Agents Mandatory for Patients With Bone Metastatic Castration-Resistant Prostate Cancer. J Clin Oncol, 44(27), 2648–2649. https://doi.org/10.1200/JCO-26-01356
Morris, Michael J., and Andrew J. Armstrong. “Reply to: PCWG4: A Missed Opportunity to Make Bone-Protective Agents Mandatory for Patients With Bone Metastatic Castration-Resistant Prostate Cancer.” J Clin Oncol 44, no. 27 (September 20, 2026): 2648–49. https://doi.org/10.1200/JCO-26-01356.
Morris MJ, Armstrong AJ. Reply to: PCWG4: A Missed Opportunity to Make Bone-Protective Agents Mandatory for Patients With Bone Metastatic Castration-Resistant Prostate Cancer. J Clin Oncol. 2026 Sep 20;44(27):2648–9.
Morris, Michael J., and Andrew J. Armstrong. “Reply to: PCWG4: A Missed Opportunity to Make Bone-Protective Agents Mandatory for Patients With Bone Metastatic Castration-Resistant Prostate Cancer.” J Clin Oncol, vol. 44, no. 27, Sept. 2026, pp. 2648–49. Pubmed, doi:10.1200/JCO-26-01356.
Morris MJ, Armstrong AJ. Reply to: PCWG4: A Missed Opportunity to Make Bone-Protective Agents Mandatory for Patients With Bone Metastatic Castration-Resistant Prostate Cancer. J Clin Oncol. 2026 Sep 20;44(27):2648–2649.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
September 20, 2026
Volume
44
Issue
27
Start / End Page
2648 / 2649
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis